Inulin and oligofructose in chronic inflammatory bowel disease - PubMed (original) (raw)
Review
. 2007 Nov;137(11 Suppl):2572S-2575S.
doi: 10.1093/jn/137.11.2572S.
Affiliations
- PMID: 17951505
- DOI: 10.1093/jn/137.11.2572S
Free article
Review
Inulin and oligofructose in chronic inflammatory bowel disease
Celine H M Leenen et al. J Nutr. 2007 Nov.
Free article
Abstract
Crohn's disease and ulcerative colitis, also called chronic inflammatory bowel diseases (IBD), affect up to 500 per 100,000 persons in the Western world. Recent studies in the etiology of IBD suggest that these diseases are caused by a combination of genetic, environmental, and immunological factors. Results from humans and especially animal models of colitis reported by our group and others have indicated that these diseases result from a lack of tolerance to resident intestinal bacteria in genetically susceptible hosts. Probiotic bacteria have health-promoting effects for the host when ingested and have also shown efficacy in ulcerative colitis and refractory pouchitis. In light of the efficacy of providing probiotic bacteria to patients with IBD, there has been interest in the prophylactic and therapeutic potential of inulin, oligofructose, and other prebiotics for patients with or at risk of IBD. Prebiotics are nondigestible dietary oligosaccharides that affect the host by selectively stimulating growth, activity, or both of selective intestinal (probiotic) bacteria. Prebiotics are easy to administer and, in contrast to probiotic therapy, do not require administration of large amounts of (live) bacteria and are therefore easier to administer. Studies using prebiotics, especially beta-fructan oligosaccharides, for the treatment of chronic intestinal inflammation have shown benefit in animal models of colitis. Studies using these prebiotics alone or in combination with probiotics are emerging and have shown promise. These dietary therapies could lead to novel treatments for these chronic debilitating diseases.
Similar articles
- Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
Orel R, Kamhi Trop T. Orel R, et al. World J Gastroenterol. 2014 Sep 7;20(33):11505-24. doi: 10.3748/wjg.v20.i33.11505. World J Gastroenterol. 2014. PMID: 25206258 Free PMC article. Review. - Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M, Poola S, Ali S, Samiullah S, Tahan V. Naseer M, et al. Curr Clin Pharmacol. 2020;15(3):216-233. doi: 10.2174/1574884715666200312100237. Curr Clin Pharmacol. 2020. PMID: 32164516 Review. - Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P, Dray X, Sokol H, Marteau P. Seksik P, et al. Mol Nutr Food Res. 2008 Aug;52(8):906-12. doi: 10.1002/mnfr.200700147. Mol Nutr Food Res. 2008. PMID: 18384087 Review. - Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
Schultz M, Schölmerich J, Rath HC. Schultz M, et al. Dig Dis. 2003;21(2):105-28. doi: 10.1159/000073243. Dig Dis. 2003. PMID: 14571109 Review. - Probiotics and inflammatory bowel disease: is there a scientific rationale?
Shanahan F. Shanahan F. Inflamm Bowel Dis. 2000 May;6(2):107-15. doi: 10.1097/00054725-200005000-00007. Inflamm Bowel Dis. 2000. PMID: 10833070 Review.
Cited by
- Unraveling the web of defense: the crucial role of polysaccharides in immunity.
Shen Y, Zhao H, Wang X, Wu S, Wang Y, Wang C, Zhang Y, Zhao H. Shen Y, et al. Front Immunol. 2024 Oct 25;15:1406213. doi: 10.3389/fimmu.2024.1406213. eCollection 2024. Front Immunol. 2024. PMID: 39524445 Free PMC article. Review. - Health Effects and Mechanisms of Inulin Action in Human Metabolism.
Alonso-Allende J, Milagro FI, Aranaz P. Alonso-Allende J, et al. Nutrients. 2024 Sep 2;16(17):2935. doi: 10.3390/nu16172935. Nutrients. 2024. PMID: 39275251 Free PMC article. Review. - Colorectal cancer and inulin supplementation: the good, the bad, and the unhelpful.
Oliero M, Alaoui AA, McCartney C, Santos MM. Oliero M, et al. Gastroenterol Rep (Oxf). 2024 Jul 9;12:goae058. doi: 10.1093/gastro/goae058. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 38984069 Free PMC article. Review. - Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics.
Bilal M, Ashraf S, Zhao X. Bilal M, et al. Front Nutr. 2022 Jul 22;9:931458. doi: 10.3389/fnut.2022.931458. eCollection 2022. Front Nutr. 2022. PMID: 35938108 Free PMC article. Review. - Structural Characteristics of Inulin and Microcrystalline Cellulose and Their Effect on Ameliorating Colitis and Altering Colonic Microbiota in Dextran Sodium Sulfate-Induced Colitic Mice.
Qiao H, Zhao T, Yin J, Zhang Y, Ran H, Chen S, Wu Z, Zhang R, Wang X, Gan L, Wang J. Qiao H, et al. ACS Omega. 2022 Mar 23;7(13):10921-10932. doi: 10.1021/acsomega.1c06552. eCollection 2022 Apr 5. ACS Omega. 2022. PMID: 35415348 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical